0000950170-24-017069.txt : 20240220
0000950170-24-017069.hdr.sgml : 20240220
20240220160013
ACCESSION NUMBER: 0000950170-24-017069
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giffin Brett A.
CENTRAL INDEX KEY: 0001892921
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 24653085
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
ownership.xml
4
X0508
4
2024-02-20
0001492674
T2 Biosystems, Inc.
TTOO
0001892921
Giffin Brett A.
101 HARTWELL AVENUE
LEXINGTON
MA
02421
false
true
false
false
Chief Commercial Officer
false
Common Stock
2024-02-20
4
M
false
13
A
77
D
Restricted Stock Units
2024-02-20
4
A
false
13
0
A
Common Stock
13
13
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On February 20, 2022 the reporting person was granted 40 RSU's that vest in three equal installments commencing on February 20, 2023.
/s/ John Sprague, Attorney-in-fact
2024-02-20